11 November 2019 - A funding boost is set to provide free EpiPens to 2500 children at risk of serious allergic reactions.
EpiPens cost between $120 and $350 each and are not publicly funded by PHARMAC.
Allergy New Zealand CEO Mark Dixon told Mike Hosking they're joining forces with Pub Charity to fund the EpiPens for those most in need.